Deficiencies and Dysregulation of STAT Pathways That Drive Inborn Errors of Immunity: Lessons from Patients and Mouse Models of Disease.

The STAT family proteins provide critical signals for immune cell development, differentiation, and proinflammatory and anti-inflammatory responses. Inborn errors of immunity (IEIs) are caused by single gene defects leading to immune deficiency and/or dysregulation, and they have provided opportunities to identify genes important for regulating the human immune response. Studies of patients with IEIs due to altered STAT signaling, and mouse models of these diseases, have helped to shape current understanding of the mechanisms whereby STAT signaling and protein interactions regulate immunity. Although many STAT signaling pathways are shared, clinical and immune phenotypes in patients with monogenic defects of STAT signaling highlight both redundant and nonredundant pathways. In this review, we provide an overview of the shared and unique signaling pathways used by STATs, phenotypes of IEIs with altered STAT signaling, and recent discoveries that have provided insight into the human immune response and treatment of disease.

[1]  T. Chatila,et al.  Severe Allergic Dysregulation Due to A Gain of Function Mutation in the Transcription Factor STAT6. , 2023, The Journal of allergy and clinical immunology.

[2]  Phillip A. Richmond,et al.  Human germline heterozygous gain-of-function STAT6 variants cause severe allergic disease , 2022, medRxiv.

[3]  Y. Ohya,et al.  STAT6 gain-of-function variant exacerbates multiple allergic symptoms. , 2022, The Journal of allergy and clinical immunology.

[4]  Timothy J. Peters,et al.  STAT3 gain-of-function mutations connect leukemia with autoimmune disease by pathological NKG2Dhi CD8+ T cell dysregulation and accumulation. , 2022, Immunity.

[5]  J. Darnell,et al.  The JAK-STAT pathway at 30: Much learned, much more to do , 2022, Cell.

[6]  P. J. van der Spek,et al.  A germline STAT6 gain-of-function variant is associated with early-onset allergies. , 2022, The Journal of allergy and clinical immunology.

[7]  Erica G. Schmitt,et al.  A human STAT3 gain-of-function variant confers T cell dysregulation without predominant Treg dysfunction in mice , 2022, JCI insight.

[8]  D. Liggitt,et al.  Cutting Edge: Systemic Autoimmunity in Murine STAT3 Gain-of-Function Syndrome Is Characterized by Effector T Cell Expansion in the Absence of Overt Regulatory T Cell Dysfunction , 2022, The Journal of Immunology.

[9]  A. Gamero,et al.  Exposing the Two Contrasting Faces of STAT2 in Inflammation. , 2022, Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research.

[10]  H. Canatan,et al.  A novel gain‐of‐function mutation in STAT5B is associated with treatment‐resistant severe atopic dermatitis , 2022, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.

[11]  Timothy J. Peters,et al.  STAT5B restrains human B-cell differentiation to maintain humoral immune homeostasis. , 2022, Journal of Allergy and Clinical Immunology.

[12]  H. Reyburn,et al.  Aberrant inflammatory responses to type I interferon in STAT2 or IRF9 deficiency. , 2022, The Journal of allergy and clinical immunology.

[13]  J. Frelinger,et al.  Mouse Model of a Human STAT4 Point Mutation That Predisposes to Disseminated Coccidiomycosis , 2022, ImmunoHorizons.

[14]  Xiaoying Hu,et al.  The JAK/STAT signaling pathway: from bench to clinic , 2021, Signal Transduction and Targeted Therapy.

[15]  E. Klechevsky,et al.  STAT3 Gain-of-Function Mutations Underlie Deficiency in Human Nonclassical CD16+ Monocytes and CD141+ Dendritic Cells , 2021, The Journal of Immunology.

[16]  J. O’Shea,et al.  JAK-STAT signaling in human disease: From genetic syndromes to clinical inhibition. , 2021, The Journal of allergy and clinical immunology.

[17]  S. Hambleton,et al.  Human Disease Phenotypes Associated with Loss and Gain of Function Mutations in STAT2: Viral Susceptibility and Type I Interferonopathy , 2021, Journal of Clinical Immunology.

[18]  A. Gennery,et al.  STAT3 Hyper-IgE Syndrome—an Update and Unanswered Questions , 2021, Journal of Clinical Immunology.

[19]  M. Cooper,et al.  Genetic Mosaicism as a Cause of Inborn Errors of Immunity , 2021, Journal of Clinical Immunology.

[20]  Xiaodong Zhao,et al.  Clinical Relevance of Gain- and Loss-of-Function Germline Mutations in STAT1: A Systematic Review , 2021, Frontiers in Immunology.

[21]  B. Zha,et al.  The roles of STAT6 in regulating B cell fate, activation, and function. , 2021, Immunology letters.

[22]  Mark S. Anderson,et al.  A human mutation in STAT3 promotes type 1 diabetes through a defect in CD8+ T cell tolerance , 2021, The Journal of experimental medicine.

[23]  Erica G. Schmitt,et al.  Genetics of Pediatric Immune-Mediated Diseases and Human Immunity. , 2021, Annual review of immunology.

[24]  C. Duncan,et al.  Life-Threatening Influenza, Hemophagocytic Lymphohistiocytosis and Probable Vaccine-Strain Varicella in a Novel Case of Homozygous STAT2 Deficiency , 2021, Frontiers in Immunology.

[25]  M. Raffeld,et al.  JAK inhibition in early onset somatic, nonclonal STAT5B gain-of-function disease. , 2020, The journal of allergy and clinical immunology. In practice.

[26]  K. Schwarz,et al.  Early-onset autoimmunity associated with SOCS1 haploinsufficiency , 2020, Nature Communications.

[27]  Devin M. Jones,et al.  Dynamic Roles for IL-2–STAT5 Signaling in Effector and Regulatory CD4+ T Cell Populations , 2020, The Journal of Immunology.

[28]  J. Casanova,et al.  Human STAT1 Gain-of-Function Heterozygous Mutations: Chronic Mucocutaneous Candidiasis and Type I Interferonopathy , 2020, Journal of Clinical Immunology.

[29]  Douglas R. McDonald,et al.  Immune dysregulation and multisystem inflammatory syndrome in children (MIS-C) in individuals with haploinsufficiency of SOCS1 , 2020, Journal of Allergy and Clinical Immunology.

[30]  J. Orange,et al.  Complex Autoinflammatory Syndrome Unveils Fundamental Principles of JAK1 Kinase Transcriptional and Biochemical Function , 2020, Immunity.

[31]  Pei-lin Wu,et al.  A TYK2 Gene Mutation c.2395G>A Leads to TYK2 Deficiency: A Case Report and Literature Review , 2020, Frontiers in Pediatrics.

[32]  M. Hernandez,et al.  Systemic Type I IFN Inflammation in Human ISG15 Deficiency Leads to Necrotizing Skin Lesions , 2020, Cell reports.

[33]  B. Baradaran,et al.  Targeting STAT3 in cancer and autoimmune diseases. , 2020, European journal of pharmacology.

[34]  J. Casanova,et al.  JAK Inhibitor Therapy in a Child with Inherited USP18 Deficiency. , 2020, The New England journal of medicine.

[35]  J. Casanova,et al.  Human Inborn Errors of Immunity: 2022 Update on the Classification from the International Union of Immunological Societies Expert Committee , 2022, Journal of Clinical Immunology.

[36]  Ryan L. Collins,et al.  The mutational constraint spectrum quantified from variation in 141,456 humans , 2020, Nature.

[37]  O. Ohara,et al.  Human Gain-of-Function STAT1 Mutation disturbs IL-17 Immunity in Mice. , 2019, International immunology.

[38]  J. Casanova,et al.  Homozygous STAT2 gain-of-function mutation by loss of USP18 activity in a patient with type I interferonopathy , 2019, bioRxiv.

[39]  S. Lovell,et al.  Severe type I interferonopathy and unrestrained interferon signaling due to a homozygous germline mutation in STAT2 , 2019, Science Immunology.

[40]  S. Tangye,et al.  Flow Cytometric-Based Analysis of Defects in Lymphocyte Differentiation and Function Due to Inborn Errors of Immunity , 2019, Front. Immunol..

[41]  R. Geha,et al.  A novel variant in STAT2 presenting with hemophagocytic lymphohistiocytosis. , 2019, The Journal of allergy and clinical immunology.

[42]  M. Baldridge,et al.  A Human STAT1 Gain-of-Function Mutation Impairs CD8+ T Cell Responses against Gammaherpesvirus 68 , 2019, Journal of Virology.

[43]  P. Rohrlich,et al.  Clinical Aspects of STAT3 Gain-of-Function Germline Mutations: A Systematic Review. , 2019, The journal of allergy and clinical immunology. In practice.

[44]  J. Casanova,et al.  Homozygosity for TYK2 P1104A underlies tuberculosis in about 1% of patients in a cohort of European ancestry , 2019, Proceedings of the National Academy of Sciences.

[45]  J. Anaya,et al.  Primary immunodeficiency and autoimmunity: A comprehensive review. , 2019, Journal of autoimmunity.

[46]  Nicole M. Chapman,et al.  Helper T cell differentiation , 2019, Cellular & Molecular Immunology.

[47]  Yuan Zhang,et al.  Human TH9 differentiation is dependent on signal transducer and activator of transcription (STAT) 3 to restrain STAT1‐mediated inhibition , 2019, The Journal of allergy and clinical immunology.

[48]  L. Forbes,et al.  JAK/STAT proteins and their biological impact on NK cell development and function. , 2019, Molecular immunology.

[49]  J. Orange,et al.  Human STAT5b mutation causes dysregulated human natural killer cell maturation and impaired lytic function. , 2020, The Journal of allergy and clinical immunology.

[50]  S. Holland,et al.  TNF overproduction impairs epithelial staphylococcal response in hyper IgE syndrome , 2018, The Journal of clinical investigation.

[51]  D. Chaussabel,et al.  A recessive form of hyper-IgE syndrome by disruption of ZNF341-dependent STAT3 transcription and activity , 2018, Science Immunology.

[52]  A. Schäffer,et al.  ZNF341 controls STAT3 expression and thereby immunocompetence , 2018, Science Immunology.

[53]  M. Dattani,et al.  Dominant-negative STAT5B mutations cause growth hormone insensitivity with short stature and mild immune dysregulation , 2018, Nature Communications.

[54]  S. Yao,et al.  The molecular basis of JAK/STAT inhibition by SOCS1 , 2018, Nature Communications.

[55]  J. Casanova,et al.  Paracoccidioidomycosis Associated With a Heterozygous STAT4 Mutation and Impaired IFN-&ggr; Immunity , 2017, The Journal of infectious diseases.

[56]  Yuan Zhang,et al.  PD-L1 up-regulation restrains Th17 cell differentiation in STAT3 loss- and STAT1 gain-of-function patients , 2017, The Journal of experimental medicine.

[57]  H. Maecker,et al.  Systems approach to uncover signaling networks in primary immunodeficiency diseases. , 2017, The Journal of allergy and clinical immunology.

[58]  J. Casanova,et al.  A novel kindred with inherited STAT2 deficiency and severe viral illness. , 2017, The Journal of allergy and clinical immunology.

[59]  S. Mostafavi,et al.  JAK1 gain-of-function causes an autosomal dominant immune dysregulatory and hypereosinophilic syndrome. , 2017, The Journal of allergy and clinical immunology.

[60]  C. V. D. Schoot,et al.  Germline activating TYK2 mutations in pediatric patients with two primary acute lymphoblastic leukemia occurrences , 2017, Leukemia.

[61]  Yuka Kanno,et al.  Mechanisms and consequences of Jak–STAT signaling in the immune system , 2017, Nature Immunology.

[62]  Ming Yan,et al.  STAT2 is an essential adaptor in USP18-mediated suppression of type I interferon signaling , 2017, Nature Structural &Molecular Biology.

[63]  M. Raffeld,et al.  Somatic STAT5b gain-of-function mutations in early onset nonclonal eosinophilia, urticaria, dermatitis, and diarrhea. , 2017, Blood.

[64]  M. Farrar,et al.  STAT5 and CD4 + T Cell Immunity , 2017, F1000Research.

[65]  S. Nejentsev,et al.  Biallelic JAK1 mutations in immunodeficient patient with mycobacterial infection , 2016, Nature Communications.

[66]  S. Watowich,et al.  STAT3 signaling in immunity. , 2016, Cytokine & growth factor reviews.

[67]  J. Casanova,et al.  Unique and shared signaling pathways cooperate to regulate the differentiation of human CD4+ T cells into distinct effector subsets , 2016, The Journal of experimental medicine.

[68]  W. V. van IJcken,et al.  Human USP18 deficiency underlies type 1 interferonopathy leading to severe pseudo-TORCH syndrome , 2016, The Journal of experimental medicine.

[69]  J. Casanova,et al.  Heterozygous STAT1 gain-of-function mutations underlie an unexpectedly broad clinical phenotype. , 2016, Blood.

[70]  S. Wakana,et al.  Hyperactivation of JAK1 tyrosine kinase induces stepwise, progressive pruritic dermatitis. , 2016, The Journal of clinical investigation.

[71]  S. Smeekens,et al.  Gain‐of‐function STAT1 mutations impair STAT3 activity in patients with chronic mucocutaneous candidiasis (CMC) , 2015, European journal of immunology.

[72]  J. Casanova,et al.  Monogenic mutations differentially affect the quantity and quality of T follicular helper cells in patients with human primary immunodeficiencies. , 2015, The Journal of allergy and clinical immunology.

[73]  J. Milner,et al.  The Ying and Yang of STAT3 in Human Disease , 2015, Journal of Clinical Immunology.

[74]  W. Leonard,et al.  Opposing roles of STAT1 and STAT3 in IL-21 function in CD4+ T cells , 2015, Proceedings of the National Academy of Sciences.

[75]  T. Jacques,et al.  Signal transducer and activator of transcription 2 deficiency is a novel disorder of mitochondrial fission , 2015, Brain : a journal of neurology.

[76]  J. Kere,et al.  Autoimmunity, hypogammaglobulinemia, lymphoproliferation, and mycobacterial disease in patients with activating mutations in STAT3. , 2015, Blood.

[77]  Elisha D O Roberson,et al.  Early-onset lymphoproliferation and autoimmunity caused by germline STAT3 gain-of-function mutations. , 2015, Blood.

[78]  J. Casanova,et al.  Human intracellular ISG15 prevents interferon-α/β over-amplification and auto-inflammation , 2014, Nature.

[79]  J. Kere,et al.  Activating germline mutations in STAT3 cause early-onset multi-organ autoimmune disease , 2014, Nature Genetics.

[80]  S. Tangye,et al.  STAT3 is a central regulator of lymphocyte differentiation and function. , 2014, Current opinion in immunology.

[81]  S. Holland,et al.  A mouse model of HIES reveals pro- and anti-inflammatory functions of STAT3. , 2014, Blood.

[82]  C. Rice,et al.  Interferon-stimulated genes: a complex web of host defenses. , 2014, Annual review of immunology.

[83]  J. Casanova,et al.  Naive and memory human B cells have distinct requirements for STAT3 activation to differentiate into antibody-secreting plasma cells , 2013, The Journal of experimental medicine.

[84]  H. Fuchs,et al.  An ENU mutagenesis-derived mouse model with a dominant Jak1 mutation resembling phenotypes of systemic autoimmune disease. , 2013, The American journal of pathology.

[85]  Alexander A. Morgan,et al.  Differentiating the roles of STAT5B and STAT5A in human CD4+ T cells. , 2013, Clinical immunology.

[86]  A. Morris,et al.  STAT4-Dependent and -Independent Th2 Responses Correlate with Protective Immunity against Lung Infection with Pneumocystis murina , 2013, The Journal of Immunology.

[87]  N. McGovern,et al.  STAT2 deficiency and susceptibility to viral illness in humans , 2013, Proceedings of the National Academy of Sciences.

[88]  J. Casanova,et al.  Mycobacterial Disease and Impaired IFN-γ Immunity in Humans with Inherited ISG15 Deficiency , 2012, Science.

[89]  J. Casanova,et al.  Inborn errors of human STAT1: allelic heterogeneity governs the diversity of immunological and infectious phenotypes , 2012, Current Opinion in Immunology.

[90]  Kari Christine Nadeau,et al.  The STAT5b Pathway Defect and Autoimmunity , 2012, Front. Immun..

[91]  J. Casanova,et al.  Functional STAT3 deficiency compromises the generation of human T follicular helper cells. , 2012, Blood.

[92]  R. Plenge,et al.  JAK and STAT signaling molecules in immunoregulation and immune-mediated disease. , 2012, Immunity.

[93]  S. Holland,et al.  A critical role for STAT3 transcription factor signaling in the development and maintenance of human T cell memory. , 2011, Immunity.

[94]  A. Hoischen,et al.  STAT1 mutations in autosomal dominant chronic mucocutaneous candidiasis. , 2011, The New England journal of medicine.

[95]  Hong Liu,et al.  Interleukin-27-mediated suppression of human Th17 cells is associated with activation of STAT1 and suppressor of cytokine signaling protein 1. , 2011, Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research.

[96]  Sami Al-Hajjar,et al.  B cell–intrinsic signaling through IL-21 receptor and STAT3 is required for establishing long-lived antibody responses in humans , 2010, The Journal of experimental medicine.

[97]  Graham M Lord,et al.  The transcription factors T-bet and GATA-3 control alternative pathways of T-cell differentiation through a shared set of target genes , 2009, Proceedings of the National Academy of Sciences.

[98]  Lionel B Ivashkiv,et al.  Cross-regulation of signaling pathways by interferon-gamma: implications for immune responses and autoimmune diseases. , 2009, Immunity.

[99]  J. Casanova,et al.  A partial form of recessive STAT1 deficiency in humans. , 2009, The Journal of clinical investigation.

[100]  S. Tangye,et al.  Deficiency of Th17 cells in hyper IgE syndrome due to mutations in STAT3 , 2008, The Journal of experimental medicine.

[101]  George D. Kalliolias,et al.  IL-27 Activates Human Monocytes via STAT1 and Suppresses IL-10 Production but the Inflammatory Functions of IL-27 Are Abrogated by TLRs and p381 , 2008, The Journal of Immunology.

[102]  W. Paul,et al.  Impaired TH17 cell differentiation in subjects with autosomal dominant hyper-IgE syndrome , 2008, Nature.

[103]  Bodo Grimbacher,et al.  STAT3 mutations in the hyper-IgE syndrome. , 2007, The New England journal of medicine.

[104]  H. Takada,et al.  Dominant-negative mutations in the DNA-binding domain of STAT3 cause hyper-IgE syndrome , 2007, Nature.

[105]  T. Naka,et al.  IL-6-dependent and -independent pathways in the development of interleukin 17-producing T helper cells , 2007, Proceedings of the National Academy of Sciences.

[106]  Chen Dong,et al.  STAT3 Regulates Cytokine-mediated Generation of Inflammatory Helper T Cells* , 2007, Journal of Biological Chemistry.

[107]  T. Morio,et al.  Human tyrosine kinase 2 deficiency reveals its requisite roles in multiple cytokine signals involved in innate and acquired immunity. , 2006, Immunity.

[108]  J. Casanova,et al.  Novel STAT1 Alleles in Otherwise Healthy Patients with Mycobacterial Disease , 2006, PLoS genetics.

[109]  D. Hebenstreit,et al.  Signaling mechanisms, interaction partners, and target genes of STAT6. , 2006, Cytokine & growth factor reviews.

[110]  Bogdan Tanasa,et al.  Regulation of Th2 differentiation and Il4 locus accessibility. , 2006, Annual review of immunology.

[111]  L. Hennighausen,et al.  Stat5a/b are essential for normal lymphoid development and differentiation. , 2006, Proceedings of the National Academy of Sciences of the United States of America.

[112]  K. Knobeloch,et al.  ISG15, an Interferon-Stimulated Ubiquitin-Like Protein, Is Not Essential for STAT1 Signaling and Responses against Vesicular Stomatitis and Lymphocytic Choriomeningitis Virus , 2005, Molecular and Cellular Biology.

[113]  Lin Ying Liu,et al.  IL-5 and Granulocyte-Macrophage Colony-Stimulating Factor Activate STAT3 and STAT5 and Promote Pim-1 and Cyclin D3 Protein Expression in Human Eosinophils1 , 2004, The Journal of Immunology.

[114]  F. D. de Sauvage,et al.  IL-27 regulates IL-12 responsiveness of naïve CD4+ T cells through Stat1-dependent and -independent mechanisms , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[115]  B. Little,et al.  Growth hormone insensitivity associated with a STAT5b mutation. , 2003, The New England journal of medicine.

[116]  Sami Al-Hajjar,et al.  Impaired response to interferon-α/β and lethal viral disease in human STAT1 deficiency , 2003, Nature Genetics.

[117]  S. Orkin,et al.  Dysregulation of protein modification by ISG15 results in brain cell injury. , 2002, Genes & development.

[118]  Xiaoyu Hu,et al.  Sensitization of IFN-γ Jak-STAT signaling during macrophage activation , 2002, Nature Immunology.

[119]  Jianfei Yang,et al.  T-bet is a STAT1-induced regulator of IL-12R expression in naïve CD4+ T cells , 2002, Nature Immunology.

[120]  P. Veys,et al.  Unexpected and variable phenotypes in a family with JAK3 deficiency , 2001, Genes and Immunity.

[121]  Steven M. Holland,et al.  Impairment of Mycobacterial But Not Viral Immunity by a Germline Human STAT1 Mutation , 2001, Science.

[122]  C. Schindler,et al.  Immune response in Stat2 knockout mice. , 2000, Immunity.

[123]  H. Pircher,et al.  Partial impairment of cytokine responses in Tyk2-deficient mice. , 2000, Immunity.

[124]  Shizuo Akira,et al.  Functional Roles of STAT Family Proteins: Lessons from Knockout Mice , 1999, Stem cells.

[125]  R. Schreiber,et al.  Disruption of the Jak1 Gene Demonstrates Obligatory and Nonredundant Roles of the Jaks in Cytokine-Induced Biologic Responses , 1998, Cell.

[126]  R. Snell,et al.  Requirement of STAT5b for sexual dimorphism of body growth rates and liver gene expression. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[127]  S. Akira,et al.  Targeted disruption of the mouse Stat3 gene leads to early embryonic lethality. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[128]  L. Hennighausen,et al.  Stat5a is mandatory for adult mammary gland development and lactogenesis. , 1997, Genes & development.

[129]  M. Kaplan,et al.  Impaired IL-12 responses and enhanced development of Th2 cells in Stat4-deficient mice , 1996, Nature.

[130]  D. Levy,et al.  Targeted Disruption of the Mouse Stat1 Gene Results in Compromised Innate Immunity to Viral Disease , 1996, Cell.

[131]  R. Schreiber,et al.  Targeted Disruption of the Stat1 Gene in Mice Reveals Unexpected Physiologic Specificity in the JAK–STAT Signaling Pathway , 1996, Cell.

[132]  H. Nakauchi,et al.  Developmental defects of lymphoid cells in Jak3 kinase-deficient mice. , 1995, Immunity.

[133]  W. Leonard,et al.  Mutation of Jak3 in a Patient with SCID: Essential Role of Jak3 in Lymphoid Development , 1995, Science.

[134]  J. Johnston,et al.  Mutations of Jak-3 gene in patients with autosomal severe combined immune deficiency (SCID) , 1995, Nature.